ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
21 Jun 2021 09:53Syndicated

Samsung Is In A Crucial Transition

Samsung is a unique company: one of the best brand names to ever come out of East Asia, covering Samsung's history, where it is today and its future

Logo
195 Views
Share
bearishKakao Games
18 Jun 2021 11:18

KRX BBIG Index Rebalance Preview: Worth a Look

There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...

Logo
469 Views
Share
14 Jun 2021 20:08

KRX Plans to Launch a New Index Called 'KOSPI 200 Top 10'

According to the KRX, it plans to launch new indices which would include the top 10 stocks in KOSPI. The name of this index is expected to be...

Logo
175 Views
Share
08 Jun 2021 17:50

Pharmaron Placement - Strong Track Record

Joint Global coordinators aim to raise around US$125m via selling shares in Pharmaron in order to aid certain convertible bond investors to hedge...

Logo
228 Views
Share
29 May 2021 06:26

Asia Shorts: Tencent, AIA, JD, CICC, Canon, Renesas, Monex, HMC, LGD, HMM, KEPCO, Innolux, Wan Hai

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
233 Views
Share
x